ABT Collar Strategy
ABT (Abbott Laboratories), in the Healthcare sector, (Medical - Devices industry), listed on NYSE.
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents.
ABT (Abbott Laboratories) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $191.93B, a trailing P/E of 35.64, a beta of 0.58 versus the broader market, a 52-week range of 81.97-137.49, average daily share volume of 12.7M, a public-listing history dating back to 1980, approximately 115K full-time employees. These structural characteristics shape how ABT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.58 indicates ABT has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 35.64 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple. ABT pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a collar on ABT?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
ABT snapshot
As of August 14, 2026, spot at $110.97, ATM IV 22.70%, IV rank 25.42%, expected move 6.51%. The collar on ABT below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this collar structure on ABT specifically: IV regime affects collar pricing on both sides; compressed ABT IV at 22.70% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 6.51% (roughly $7.22 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ABT expiries trade a higher absolute premium for lower per-day decay. Position sizing on ABT should anchor to the underlying notional of $110.97 per share and to the trader's directional view on ABT stock.
ABT collar setup
The ABT collar below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ABT at $110.97 on that close, the first option leg uses a $117.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ABT chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ABT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $110.97 | long |
| Sell 1 | Call | $117.00 | $0.68 |
| Buy 1 | Put | $105.00 | $0.63 |
ABT collar risk and reward
- Net Premium / Debit
- -$11,092.00
- Max Profit (per contract)
- $608.00
- Max Loss (per contract)
- -$592.00
- Breakeven(s)
- $110.92
- Risk / Reward Ratio
- 1.027
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
ABT collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on ABT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$592.00 |
| $24.54 | -77.9% | -$592.00 |
| $49.08 | -55.8% | -$592.00 |
| $73.61 | -33.7% | -$592.00 |
| $98.15 | -11.6% | -$592.00 |
| $122.68 | +10.6% | +$608.00 |
| $147.22 | +32.7% | +$608.00 |
| $171.75 | +54.8% | +$608.00 |
| $196.29 | +76.9% | +$608.00 |
| $220.82 | +99.0% | +$608.00 |
When traders use collar on ABT
Collars on ABT hedge an existing long ABT stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
ABT thesis for this collar
The market-implied 1-standard-deviation range for ABT extends from approximately $103.75 on the downside to $118.19 on the upside. A ABT collar hedges an existing long ABT position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current ABT IV rank near 25.42% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ABT at 22.70%. As a Healthcare name, ABT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ABT-specific events.
ABT collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ABT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ABT alongside the broader basket even when ABT-specific fundamentals are unchanged. Always rebuild the position from current ABT chain quotes before placing a trade.
Frequently asked questions
- What is a collar on ABT?
- A collar on ABT is the collar strategy applied to ABT (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With ABT stock at $110.97 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed ABT chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are ABT collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the ABT collar priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 22.70%), the computed maximum profit is $608.00 per contract and the computed maximum loss is -$592.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ABT collar?
- The breakeven for the ABT collar priced on this page is roughly $110.92 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ABT market-implied 1-standard-deviation expected move in the same options snapshot is approximately 6.51%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on ABT?
- Collars on ABT hedge an existing long ABT stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current ABT implied volatility affect this collar?
- ABT ATM IV is at 22.70% with IV rank near 25.42%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.